积突快报：医药生物板块早盘领涨，恒瑞医药等个股表现抢眼触发积突信号

腾讯自选股11-20 10:24

11月20日早盘，医药生物板块表现突出，领涨大盘。其中，化学制药、医疗服务等子板块均呈现出明显的上涨趋势。在该板块内，多只成份股交易活跃，吸引了市场的广泛关注。具体来看，恒瑞医药、华东医药、贝达药业、益方生物等个股在早盘交易中表现尤为抢眼。其中，恒瑞医药在开盘后的十分钟内即触发了“积突双信号”（用户需升级APP至最新版本、并在APP中订阅沪深净流入业务后方可查看该信号、线上新增积突榜单、助力您更好...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484525135?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-20 10:24","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484525135","market":"sh","top_or_hot":-1,"title":"积突快报：医药生物板块早盘领涨，恒瑞医药等个股表现抢眼触发积突信号","media":"腾讯自选股","content":"<div>\n<p>11月20日早盘，医药生物板块表现突出，领涨大盘。其中，化学制药、医疗服务等子板块均呈现出明显的上涨趋势。在该板块内，多只成份股交易活跃，吸引了市场的广泛关注。具体来看，恒瑞医药、华东医药、贝达药业、益方生物等个股在早盘交易中表现尤为抢眼。其中，恒瑞医药在开盘后的十分钟内即触发了“积突双信号”（用户需升级APP至最新版本、并在APP中订阅沪深净流入业务后方可查看该信号、线上新增积突榜单、助力您更好...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112010201798e43a47&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>积突快报：医药生物板块早盘领涨，恒瑞医药等个股表现抢眼触发积突信号</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n积突快报：医药生物板块早盘领涨，恒瑞医药等个股表现抢眼触发积突信号\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 10:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112010201798e43a47&s=b><strong>腾讯自选股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月20日早盘，医药生物板块表现突出，领涨大盘。其中，化学制药、医疗服务等子板块均呈现出明显的上涨趋势。在该板块内，多只成份股交易活跃，吸引了市场的广泛关注。具体来看，恒瑞医药、华东医药、贝达药业、益方生物等个股在早盘交易中表现尤为抢眼。其中，恒瑞医药在开盘后的十分钟内即触发了“积突双信号”（用户需升级APP至最新版本、并在APP中订阅沪深净流入业务后方可查看该信号、线上新增积突榜单、助力您更好...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112010201798e43a47&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1064131003.USD","symbol_name":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112010201798e43a47&s=b","article_id":"2484525135","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112010201798e43a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484525135","pubTimestamp":1732069466,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月20日早盘，医药生物板块表现突出，领涨大盘。具体来看，恒瑞医药、华东医药、贝达药业、益方生物等个股在早盘交易中表现尤为抢眼。此外，据外媒最新消息透露，内地医药巨头恒瑞医药正紧锣密鼓地筹备于2025年赴香港进行IPO募资。这一消息无疑为恒瑞医药的未来发展注入了新的动力。在医疗器械方面，中国企业开发的创新医疗器械同样表现出色，共有165个产品获批上市。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"163118":"医药生物","600276":"恒瑞医药","688382":"益方生物","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","BK0239":"医药制造","BK0012":"证金概念","BK0196":"行业龙头","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","000808.SH":"医药生物","BK0188":"融资融券","BK0028":"国家队","BK0060":"抗癌","BK0183":"MSCI概念"},"translate_title":"Accumulation Express: The pharmaceutical and biological sector led the gains in early trading, and the eye-catching performance of individual stocks such as Hengrui Medicine triggered the accumulation signal","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"163118":1,"600276":1,"688382":0.9,"000808.SH":1},"content_text":"11月20日早盘，医药生物板块表现突出，领涨大盘。其中，化学制药、医疗服务等子板块均呈现出明显的上涨趋势。在该板块内，多只成份股交易活跃，吸引了市场的广泛关注。具体来看，恒瑞医药、华东医药、贝达药业、益方生物等个股在早盘交易中表现尤为抢眼。其中，恒瑞医药在开盘后的十分钟内即触发了“积突双信号”（用户需升级APP至最新版本、并在APP中订阅沪深净流入业务后方可查看该信号、线上新增积突榜单、助力您更好发现积突股票池），其股价随即快速拉升，涨幅超过4%。截至发稿时，该股的主力资金净流入已达2.1亿元，显示出市场对其未来发展的强烈信心。此外，据外媒最新消息透露，内地医药巨头恒瑞医药（股票代码：600276.SH）正紧锣密鼓地筹备于2025年赴香港进行IPO募资。据悉，该公司已选定花旗和摩根士丹利作为牵头统筹此次香港IPO的金融机构，并计划募资约20亿美元。这一消息无疑为恒瑞医药的未来发展注入了新的动力。值得一提的是，近期医药行业的利好消息不断。在11月16日举行的2024中国医药工业发展大会与上海国际生物医药产业周上，《医药工业“十四五”期间产业升级突出进展和产业技术未来发展重点领域》报告正式发布。该报告详细总结了我国“十四五”期间医药产业的突出进展，并指出我国医药行业创新能力显著提升。报告数据显示，“十四五”以来，我国国产创新药在数量和质量上均实现了显著提升。共有113个国产创新药获批上市，这一数量是“十三五”期间获批新药数量的2.8倍。同时，这些创新药的市场规模也达到了1000亿元。在医疗器械方面，中国企业开发的创新医疗器械同样表现出色，共有165个产品获批上市。这些产品融合了深度学习、磁悬浮、增材制造、多模态成像、磁共振监测等前沿技术，展现了我国医药行业的创新实力和发展潜力。声明：股市有风险、投资需谨慎。本文章内容为公开市场资料整理、不构成投资建议。投资者在做出投资决策时、应充分考虑自身风险承受能力和投资目标。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484525135"}